RecruitingNot ApplicableNCT06531460

Nutritional Therapy Enriched With Omega-3 in Patients With Lung Resection

Effect of Perioperative Nutrition Enriched With Omega-3 on the Incidence of Infections in Oncologic Patients Following Lung Resection


Sponsor

National Institute of Respiratory Diseases, Mexico

Enrollment

310 participants

Start Date

Jul 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to analyze the effect of enriched formula with omega-3 in the 30-day incidence infection and inflammatory response following lung resection surgery in lung cancer patients.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Lung cancer diagnosis
  • Elective surgery for lung resection schedule at least four days before surgery
  • Signed informed consent.

Exclusion Criteria4

  • Acute or chronic organ failure as hepatic or renal insufficiency
  • Patients with fish-allergy
  • History of any surgery within 3 months
  • Immunocompromised patients

Interventions

DIETARY_SUPPLEMENTFish oil enteral supplementation

Omega-3 (4.2 g), administered through an enteral feeding tube, three days before surgery

DIETARY_SUPPLEMENTFish oil oral supplementation

Omega-3 (4.2 g), orally administered enriched nutritional formula, drinking at home three days before surgery

DIETARY_SUPPLEMENTEnteral nutrition without fish oil

Enteral formula without omega-3 administered through an enteral feeding tube, three days before surgery

DIETARY_SUPPLEMENTOral nutritional supplement without fish oil

Oral nutritional supplement without omega-3 orally administered, drinking at home three days before surgery


Locations(1)

National Institute of Respiratory Diseases

Mexico City, Mexico

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06531460


Related Trials